Astellas Pharma Inc. - Strategy and SWOT Report,
- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Features:
- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa (EMEA) and Oceania. It is headquartered in Tokyo, Japan and employed 17,649 people as of March 31, 2014.Reasons to Purchase:
- Company Snapshot
- Astellas Pharma Inc.: Company Overview
- Astellas Pharma Inc.: Overview and Key Facts
- Astellas Pharma Inc.: Overview
- Astellas Pharma Inc.: Key Facts
- Astellas Pharma Inc.: Key Employees
- Astellas Pharma Inc.: Key Employee Biographies
- Astellas Pharma Inc.: Major Products and Services
- Astellas Pharma Inc.: Company History
- Astellas Pharma Inc.: Management Statement
- Astellas Pharma Inc.: Locations and Subsidiaries
- Astellas Pharma Inc.: Key Competitors
- Astellas Pharma Inc.: Company Analysis
- Astellas Pharma Inc.: Business Description
- Astellas Pharma Inc.: SWOT Analysis
- Astellas Pharma Inc.: SWOT Overview
- Astellas Pharma Inc.: Strengths
- Astellas Pharma Inc.: Weaknesses
- Astellas Pharma Inc.: Opportunities
- Astellas Pharma Inc.: Threats
- Astellas Pharma Inc.: Corporate Financial Deals Activity
- Astellas Pharma Inc.: Financial Deals Overview
- Astellas Pharma Inc.: Targets and Partners
- Astellas Pharma Inc.: Top Deals 2011 - 2015YTD*
- Astellas Pharma Inc.: Advisors
- Astellas Pharma Inc.: Top Legal Advisors
- Astellas Pharma Inc.: Mergers and Acquisitions
- Astellas Pharma Inc.: Corporate Venturing
- Astellas Pharma Inc.: Partnership
- Astellas Pharma Inc.: Divestments
- Astellas Pharma Inc.: Recent Developments
- Astellas Pharma Inc.: News and Events Summary
- Astellas Pharma Inc.: Business Expansion
- Astellas Pharma Inc.: Contracts
- Astellas Pharma Inc.: Corporate Governance
- Astellas Pharma Inc.: Regulatory and Legal Events
- Astellas Pharma Inc.: Research & Development
- Appendix
- Contact Us
- Methodology
- Definitions
- About Market Line
- List of Tables
- Table 1: Astellas Pharma Inc.: Key Facts
- Table 2: Astellas Pharma Inc.: Key Employees
- Table 4: Astellas Pharma Inc.: Key Competitors
- Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Table 7: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
- Table 8: Astellas Pharma Inc.: Targets and Partners
- Table 9: Astellas Pharma Inc.: Top Deals 2011 - 2015YTD*
- Table 10: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
- Table 11: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Table 12: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Table 13: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
- Table 14: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
- Table 15: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Table 16: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Table 17: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
- Table 18: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD*2015)
- Table 19: Astellas Pharma Inc.: News and Events Summary
- Table 20: Astellas Pharma Inc.: Business Expansion
- Table 21: Astellas Pharma Inc.: Contracts
- Table 22: Astellas Pharma Inc.: Corporate Governance
- Table 23: Astellas Pharma Inc.: Regulatory and Legal Events
- Table 24: Astellas Pharma Inc.: Research & Development
- List of Figures
- Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
- Figure 3: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
- Figure 5: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD*2015)
- Figure 6: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
- Figure 7: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
- Figure 8: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
- Figure 9: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
- Figure 10: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
- Figure 11: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD*2015)
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
